Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
57
FQVTY Quote, Financials, Valuation and Earnings
Last price:
$10.65
Seasonality move
:
12.75%
Day range:
$10.80 - $10.80
52-week range:
$7.60 - $15.00
Dividend yield:
2.08%
P/E ratio:
39.47x
P/S ratio:
2.95x
P/B ratio:
5.33x
Volume:
5
Avg. volume:
128
1-year change:
24.32%
Market cap:
$1.3B
Revenue:
$470.9M
EPS (TTM):
$0.27
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Fevertree Drinks Plc has -- downside to fair value with a price target of -- per share.
FQVTY vs. S&P 500
-
Over the past 5 trading days, Fevertree Drinks Plc has underperformed the S&P 500 by -3.16% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Fevertree Drinks Plc does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Fevertree Drinks Plc has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Fevertree Drinks Plc reported revenues of --.
Earnings Growth
-
Fevertree Drinks Plc has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Fevertree Drinks Plc reported earnings per share of --.
Enterprise value:
1.5B
EV / Invested capital:
--
Price / LTM sales:
2.95x
EV / EBIT:
33.29x
EV / Revenue:
3.27x
PEG ratio (5yr expected):
0.31x
EV / Free cash flow:
21.41x
Price / Operating cash flow:
20.08x
Enterprise value / EBITDA:
26.30x
Gross Profit (TTM):
$157.5M
Return On Assets:
7.91%
Net Income Margin (TTM):
7.41%
Return On Equity:
10.28%
Return On Invested Capital:
10.28%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-01-02 | 2025-01-02 | 2025-01-02 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $348.4M | $283.7M | $289.2M | $263.5M | -- | |
| Total Assets | $432.6M | $357.2M | $389.7M | $375.4M | -- | |
| Current Liabilities | $68.2M | $68.3M | $82.2M | $64.1M | -- | |
| Total Liabilities | $70.7M | $72.5M | $100.1M | $80.7M | -- | |
| Total Equity | $361.9M | $284.7M | $289.6M | $294.7M | -- | |
| Total Debt | $138.4K | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-01-02 | 2025-01-02 | 2025-01-02 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
FQVTY
Sector
Market Cap
$1.3B
$119.3M
Price % of 52-Week High
72%
71.06%
Dividend Yield
2.08%
0%
Shareholder Yield
-0.05%
2.3%
1-Year Price Total Return
24.32%
-6.57%
Beta (5-Year)
--
0.255
Dividend yield:
2.08%
Annualized payout:
$0.00
Payout ratio:
79.93%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$10.98
200-day SMA
Sell
Level
$11.25
Bollinger Bands (100)
Sell
Level
10.31 - 12.15
Chaikin Money Flow
Sell
Level
-1.3K
20-day SMA
Sell
Level
$10.80
Relative Strength Index (RSI14)
Buy
Level
50.54
ADX Line
Buy
Level
17.52
Williams %R
Neutral
Level
-53
50-day SMA
Sell
Level
$10.80
MACD (12, 26)
Buy
Level
0.05
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Sell
Level
-3K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (9.489)
Buy
CA Score
(Annual)
Level (1.7462)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-2.8103)
Buy
Piotroski F Score
(Annual)
Level (9)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Fevertree Drinks Plc operates as a holding and investment company. It manufactures and supplies premium carbonated mixes. The firm's products include Indian tonic water, Mediterranean tonic water, elderflower tonic water, aromatic tonic water, Clementine tonic water, citrus tonic water lemon tonic water, ginger beer, ginger ale, smoky ginger ale, spiced orange ginger ale, Madagascan cola, Sicilian lemonade, lemonade, and spring soda water. It sells its products under Fever-Tree brand name to bars and restaurants. The company was founded by Charles Timothy Rolls and Timothy Daniel Gray Warrillow in 2004 and is headquartered in London, The United Kingdom.
Stock Forecast FAQ
In the current month, FQVTY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The FQVTY average analyst price target in the past 3 months is --.
-
Where Will Fevertree Drinks Plc Stock Be In 1 Year?
According to analysts, the consensus estimate is that Fevertree Drinks Plc share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Fevertree Drinks Plc?
Analysts are divided on their view about Fevertree Drinks Plc share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Fevertree Drinks Plc is a Sell and believe this share price will rise from its current level to --.
-
What Is Fevertree Drinks Plc's Price Target?
The price target for Fevertree Drinks Plc over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is FQVTY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Fevertree Drinks Plc is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of FQVTY?
You can purchase shares of Fevertree Drinks Plc via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Fevertree Drinks Plc shares.
-
What Is The Fevertree Drinks Plc Share Price Today?
Fevertree Drinks Plc was last trading at $10.65 per share. This represents the most recent stock quote for Fevertree Drinks Plc. Yesterday, Fevertree Drinks Plc closed at $10.80 per share.
-
How To Buy Fevertree Drinks Plc Stock Online?
In order to purchase Fevertree Drinks Plc stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get FQVTY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FQVTY
Sector
P/E ratio
39.47x
16.72x
PEG ratio
0.31x
0.13x
P/B ratio
5.33x
1.49x
Price / LTM sales
2.95x
0.52x
Growth Metrics
FQVTY
Sector
Revenue growth
--
2.99%
Earnings growth
--
3.56%
Revenue (5-year growth)
7.22%
3.32%
Earnings forecast
--
$0.28
Profitability
FQVTY
Sector
Profitability FY 2024
$164.6M
$263.1M
Return on invested capital
10.28%
4.37%
Return on assets
7.91%
3.04%
Return on equity
10.28%
7.48%
Earnings Date
Last Earnings Date
Sep
11
Next Earnings Date
Mar
24
Estimated Next Earnings Date
Dec
11
Balance Sheet
FQVTY
Sector
Total cash
$120.5M
$85.8M
Short term investments
--
$31.1M
Total assets
$403.1M
$1.1B
Long term debt
--
$6.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 6.15% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.93% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 9.59% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
